Companies/US/ACAD

ACADIA PHARMACEUTICALS INC.

Last · NASDAQ$19.25+0.63 (+3.38%)close · yahoo · 9h ago
Vol 1.64M ≈ 31.62M
Market cap$3.30B171.2M sh
P/E · TTM8.6fwd 20.9 · eps 2.23
Beta0.89vs S&P 500
Div yield0.00%annual · TTM
52w range
$18.39$30.96
Volume1.6Msession

Issuer

Legal nameACADIA PHARMACEUTICALS INC.
HQUnited States (US)
ListingUS ACAD
ISINUS0042251084
LEI529900O3044NO0PEA039
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001070494
CIK0001070494
Websitewww.acadia.com
LinkedIn
Employees797
AddressACADIA Pharmaceuticals, Inc. 12830 El Camino Real 92130-3331, San Diego +858 558 2871
Headline financial metrics
Revenue$1.1B
Operating income$86.4M
Net income$380.5M
Free cash flow$124.5M
Operating margin7.6%
Net margin33.4%
Return on equity29.1%
PeriodTTM 2026-06-30
Loading chart…

OpenFilings analyst

Our analyst

10-K · 2026-02-26

From latest 10-K · 2026-02-26

  • Accumulated Deficit High

Red flags

  • Accumulated Deficit High — Accumulated deficit / equity 148%

Upcoming earnings

1 event
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
$0.18
Est. revenue
332.4M
View upcoming earnings →

Earnings transcripts

7 recent

Documents

FormReporting forFiledFlags
proxy2026 Proxy StatementIR
—2026-12-31≈0
8-KCurrent Report (8-K)
—2026-09-240
8-K8-K: Other Events
2026-09-112026-09-110
4
2026-08-052026-08-070
10-Q
2026-06-302026-08-05 1
Showing 5 of 221 filings